Corroborating these findings, a 12-year follow-up study by Araki S et al. observed a significant elevation of the urinary L-FABP in T2DM who had 50% of GFR decline and incidence of cardiovascular disease [79]. This evidence concerns the gene FABP1 and cardiovascular disorder.